My understanding is that 25-30% profit with most of the US sales going through the WIC programme is very optimistic - maybe 5% at best?
My educated guess is that A2M management haven’t been asleep at the wheel but made an offer under the FDA exemption to supply a limited number of tins at a minimum margin. They would surely rather direct product to the high margin China market at this point while keeping a door open in the US but under specific terms.
Of course they could all be out playing golf but I think the former is more likely. Come Aug 29th I guess we’ll know more!
Ann: Deferral of FDA consideration of enforcement discretion, page-103
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.77 |
Change
0.130(1.96%) |
Mkt cap ! $4.894B | |||
| Open | High | Low | Value | Volume |
| $6.63 | $6.77 | $6.63 | $10.00M | 1.485M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2420 | $6.76 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.77 | 37726 | 4 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |